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Abstract
Background: Benzo(a)pyrene (BaP), anthracene (ANTH) and chrysene (CHRY) are polynuclear
aromatic hydrocarbons (PAHs) implicated in renal toxicity and carcinogenesis. These PAHs elicit
cell type-specific effects that help predict toxicity outcomes in vitro and in vivo. While BaP and
ANTH selectively injure glomerular mesangial cells, and CHRY targets cortico-tubular epithelial
cells, binary or ternary mixtures of these hydrocarbons markedly reduce the overall cytotoxic
potential of individual hydrocarbons.
Methods: To study the biochemical basis of these antagonistic interactions, renal glomerular
mesangial cells were challenged with BaP alone (0.03 – 30 µM) or in the presence of ANTH (3 µM)
or CHRY (3 µM) for 24 hr. Total RNA and protein will be harvested for Northern analysis and
measurements of aryl hydrocarbon hydroxylase (AHH) and ethoxyresorufin-O-deethylase
(EROD) activity, respectively, to evaluate cytochrome P450 mRNA and protein inducibility.
Cellular hydrocarbon uptake and metabolic profiles of PAHs were analyzed by high performance
liquid chromatography (HPLC).
Results: Combined hydrocarbon treatments did not influence the cellular uptake of individual
hydrocarbons. ANTH or CHRY strongly repressed BaP-inducible cytochrome P450 mRNA and
protein expression, and markedly inhibited oxidative BaP metabolism.
Conclusion: These findings indicate that antagonistic interactions among nephrocarcinogenic
PAHs involve altered expression of cytochrome P450s that modulate bioactivation profiles and
nephrotoxic/ nephrocarcinogenic potential.
Background
The biological effects of PAHs are often mediated by oxi-
dative metabolism of the parent hydrocarbon to reactive
intermediates that adduct DNA and induce oxidative
stress [1]. In the kidney, PAHs elicit cell type-specific
effects that differentially influence glomerular versus
tubular epithelial cell structure and function. BaP and
ANTH selectively injure glomerular mesangial cells, while
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CHRY preferentially targets cortico-tubular epithelial cells
[2,3]. The study of single chemical effects has provided
fundamental information on the nephrotoxic potential of
specific PAHs, but human exposure to these group of
chemicals is rarely limited to a single agent, and most
often involves exposure to PAH mixtures [4]. Thus, a more
realistic approach is to evaluate the cellular, biochemical,
and molecular mechanisms by which PAHs interact to
produce additive, synergistic or antagonistic interactions.
Such studies have demonstrated that binary and ternary
mixtures of PAHs yield paradoxical antagonistic interac-
tions in vitro [3].
A toxicological interaction is a circumstance in which
exposure to two or more chemicals results in qualitative or
quantitative modulation of the biological response elic-
ited by individual agents. Toxicological interactions may
be mediated by changes in the absorption, distribution,
metabolism and excretion of one or more of the chemicals
present in the mixture. Since the ability of PAHs to com-
promise cellular and genomic integrity often requires bio-
activation by cytochrome P-450 enzymes (CYPs) to
reactive intermediates, their role in PAH-induced environ-
mental diseases is profound [5]. The interaction of PAHs
with CYPs is unique in that the expression of genes that
encode for CYP-associated activities is itself regulated by
the PAH substrates they metabolize. Shimada et al. [6]
have shown that BaP and CHRY induce Cyp1a1 and 1b1
through the aryl hydrocarbon receptor (Ahr), and that the
enzymes encoded by these genes mediate toxicity and
tumorigenicity. The Ahr belongs to the basic helix loop
helix/PAS family of proteins [7]. The activation of cyto-
plasmic complexes containing the Ahr depends on ligand
binding to the receptor, nuclear translocation and forma-
tion of active heterodimers with a nuclear protein called
Arnt [8]. The AhR-Arnt complex binds to s pecific cis-act-
ing responsive elements known as xenobiotic responsive
elements located in the promoters and enhancers of target
genes, including CYPs themselves [7]. PAHs or halogen-
ated aromatic hydrocarbons function as ligands of the
Ahr.
The present studies were conducted to evaluate profiles of
Cyp1a1 and Cyp1b1 inducibility in binary PAH mixtures,
and their impact on BaP bioactivation. Evidence is pre-
sented that chemical-specific differences in the regulation
of Cyp1a1 and Cyp1b1 contribute to differential metabolic
activation of PAHs in binary mixture. On the basis of
these findings it is concluded that interactions between
BaP, ANTH and CHRY involve altered expression of cyto-
chrome P450s that modulate bioactivation profiles and
nephrotoxic/ nephrocarcinogenic potential.
Materials and Methods
Materials
BaP, ANTH and CHRY were purchased from Sigma Chem-
ical Co. (St. Louis, MO). RPMI 1640 and M199 were pur-
chased from GIBCO-BRL (Grand Island, NY, USA). All
other chemicals were from Sigma Chemical Co.
Cell culture/chemical treatments
Rat glomerular mesangial cells in serial culture were
seeded on 6-well plates at a density of 200 cells/mm2. At
least three replicates were used for each chemical concen-
tration tested in multiple experiments. The concentrations
examined are similar to those used in previous studies and
representative of those encountered in the environment.
Cultures were challenged with selected PAHs for 24 hr at
concentrations ranging from 0.03 to 30 µM. Stock solu-
tions of PAHs were dissolved in DMSO with final DMSO
concentrations never exceeding 0.1%. Cells, RNA, or pro-
tein were harvested after chemical challenge and proc-
essed for biochemical measurements.
RNA extraction and analysis
Total RNA was extracted using Tri reagent (Molecular
Research Center, Inc., Cincinnati, OH) according to man-
ufacturer's specifications. Cells were scraped using 1.0 ml
of Tri reagent and allowed to sit at room temperature for
5 minutes to dissociate nucleoprotein complexes and
then combined with 0.2 ml chloroform, vortexed and
allowed to sit at room temperature for 2 minutes. After
centrifugation at 12,000 × g (4°C) for 15 minutes, the
upper aqueous layer was mixed with and equal volume of
isopropanol and stored at -20°C overnight. This solution
was then centrifuged for 15 minutes at 12,000 × g (4°C)
and the pellet washed with 70% ethanol, dried, and resus-
pended in 20 µl of RNase free water. RNA concentration
was determined spectrophotometrically at 260 nm.
Northern analysis
Ten µg of total RNA were dissolved in RNase free water,
mixed with 3.5 µl formamide, 1 µl of 37% formaldehyde,
1.0 µl of MOPS buffer and 15% 6X gel loading buffer, and
denatured by heating at 55°C for 10 minutes. Total RNA
was separated by electrophoresis on a formaldehyde
denaturing gel (1.2% agarose, 1 M formaldehyde and 10X
MOPS) in 1X MOPS buffer and transferred onto a nylon
membrane by capillary transfer. Membranes were dried at
room temperature, UV crosslinked and hybridized with
32P labeled cDNA probes synthesized using High Prime
(Boehringer Mannheim, Germany). The β-tubulin probe
was obtained from a 1.6 Kb fragment cloned into a pBlue-
script plasmid at the EcorI site. The Cyp1a1 probe was
obtained from a 1.2 kb Pst1 fragment from a pUC18 vec-
tor (ATCC) and the 1 kb Cyp1b1 probe was kindly pro-
vided by Dr. Colin Jefcoate (University of Wisconsin,
Madison, WI). Following hybridization the blots wereJournal of Carcinogenesis 2004, 3:12 http://www.carcinogenesis.com/content/3/1/12
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subjected to stringent washes, dried at room temperature,
and exposed to x-ray film in -80°C for 24 hours.
Cyp-related enzyme activities
Confluent subcultures of mesangial cells were grown in
100 mm dishes and treated with selected PAHs or their
mixtures for 24 hr. Cells were then scraped and collected
after the addition of 5 ml of ice-cold Tris-sucrose buffer
(pH 8.0), then centrifuged for 5 min at 50 g (4°C). The
supernatants were removed and the pellet resuspended in
300 µL of Tris-sucrose buffer. Two 100 µl aliquots con-
taining cellular protein were processed for fluorometric
enzyme analysis, while 50 µL of sample was used to meas-
ure protein concentration [9].
Aryl hydrocarbon hydroxylase (AHH) assay
Cultures were processed for measurements of AHH activ-
ity as described by Nebert and Gelboin [10]. A 100 µl aliq-
uot was combined with 1 ml of reaction mixture
containing 0.1 M HEPES (pH 8.0) and 0.4 mM NADPH.
Samples were pre-incubated at 37°C for 2 minutes, and
the reaction initiated by addition of 80 µM BaP dissolved
in 40 µM of methanol. Samples were incubated for 15
minutes and the reaction terminated by addition of 1 ml
of ice cold acetone and 3.25 ml of hexane. After vortexing,
2 ml of the organic layer was collected and extracted with
5 ml of 1 N NaOH. Samples were vortexed and the NaOH
fraction read on a spectroflurometer at a wavelength of
396 nm excitation and 522 nm emissions. The spec-
troflurometer was calibrated using authentic 3-OH BaP
standards.
Ethoxyresorufin-O-deethylase activity
Cultures were processed for measurements of EROD activ-
ity as described by Burke and Mayer [11] with modifica-
tions. Briefly, 1.2 ml of 0.1 M HEPES buffer (pH 7.5)
containing 0.1 mg of NADH, 0.1 mg of NADPH, 1.5 mg
of magnesium sulfate and 1.1 mg of BSA was added to 100
µl of sample. The tubes were incubated for 2 minutes at
37°C prior to addition of 100 mM ethoxyresorufin. 50 ml
of ethoxyresorufin was added to each tube and allowed to
incubate at 37°C for 15 minutes. The reaction was termi-
nated by addition of 2.5 ml of methanol. Samples were
incubated for an additional 2 minutes to allow for protein
flocculation and centrifuged for 10 minutes at 1500 × g.
EROD activity in the supernatant was measured fluoro-
metrically at a wavelength of 550 nm excitation and 585
nm emission as described by pohl and Fouts [12]. The
spectrofluorimeter was calibrated using authentic resoru-
fin standards.
HPLC analysis
PAH metabolism was analyzed according to the method
of Selkirk et al. [13]. Chemical separation, identification,
and quantification was performed on a high-performance
liquid chromatograph (Beckman model 334) fitted with a
Rainin Microsorb C18 reverse-phase column (4.6 × 250
mm), using a 22.5 min linear gradient of 75–100% meth-
anol at a flow rate of 1.0 ml/min. A 20 µl sample was
injected into the column. The PAH metabolites were
monitored by ultraviolet absorption at 254 nm. Identifi-
cation of metabolites was made by comparison of reten-
tion times to known standards.
Results
CYP expression profiles and toxicological interactions in 
renal cells after challenge with PAH mixtures
Antagonistic interactions among nephrotoxic/nephro-
carcingenic PAHs may be mediated by modulation of
metabolic activation profiles in mesangial cells. To test
this hypothesis, steady state levels of Cyp1a1 and Cyp1b1
mRNAs were evaluated by Northern analysis in cultured
mesangial cells treated with 0.03 – 30 µM BaP alone, or in
combination with 3 µM ANTH and CHRY (Figs 1 and 2).
Cyp1a1 mRNA was not expressed constitutively, but was
highly inducible by BaP in a concentration-dependent
manner (Fig 1A). ANTH alone (0.03 – 30 µM) did not
induce  Cyp1a1  at any concentration, but modestly
enhanced (3 µM) the mesangial cell response to BaP (3 or
30 µM). In contrast to the Cyp1a1 gene, Cyp1b1 was con-
stitutively expressed in mesangial cells (Fig 1B). Treatment
with BaP induced concentration-dependent increases in
steady state Cyp1b1 mRNA levels. ANTH alone, induced
Cyp1b1 mRNA by 5–6 fold at the higher concentrations
examined. Combined treatment of glomerular mesangial
cells with BaP (0.03 µM) and ANTH (3 µM) slightly
enhanced the response to individual hydrocarbons at the
0.03 µM concentration, but this enhancement was dissi-
pated at the higher concentrations.
The metabolic interaction between BaP and CHRY was
examined next. As expected, BaP induced Cyp1a1  and
Cyp1b1 mRNA levels in a concentration-dependent man-
ner (Figure 2, panels A and B). CHRY was also a potent
Cyp  inducer, and in fact elicited greater induction of
Cyp1a1 and Cyp1b1 mRNA than BaP (Fig 2, panels A and
B). CHRY induction of Cyp1a1 at the 3 and 30 µM concen-
trations was 2-fold higher than the response elicited by
BaP at the same concentration (Figure 2A). As with
Cyp1a1, CHRY markedly induced Cyp1b1  steady state
mRNA levels at all concentrations examined (Fig 2B).
Combined treatment of mesangial cells with BaP (0.03 –
30 µM) and CHRY (3 µM) yielded modest antagonistic
responses for both Cyp1a1 and Cyp1b1, particularly at the
highest concentrations examined. For Cyp1b1, the induc-
tion response in cells treated with 30 µM BaP and 3 µM
CHRY was reduced by 30% relative to either hydrocarbon
alone.Journal of Carcinogenesis 2004, 3:12 http://www.carcinogenesis.com/content/3/1/12
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CYP enzymatic activities in renal cells after challenge with 
PAH mixtures
Because mRNA expression does not always correlate with
changes in protein levels, measurements of EROD and
AHH activity were completed in mesangial cells treated
with PAHs alone, or in binary mixture. EROD, an enzyme
activity encoded by both Cyp1a1 and Cyp1b1, was induci-
ble by all hydrocarbons in a concentration-dependent
manner (Fig 3). Basal and inducible EROD activities in
mesangial cells were considerably lower than those in cul-
tured rat hepatocytes (not shown). A greater than 6-fold
enhancement of EROD activity was observed in cells
treated with 0.3 µM of BaP, with significant decreases
observed as the BaP concentration increased. ANTH and
CHRY also induced EROD, but induction patterns for
these hydrocarbons were remarkably different. ANTH was
a weak inducer of EROD, with only a 3-fold induction
observed at 30 µM, while CHRY elicited a greater than 14-
fold increase in enzymatic activity. As with BaP, reduc-
tions in activity were observed at the highest CHRY con-
centrations. Different profiles were observed in cells
treated with BaP in combination with either ANTH or
CHRY. Combined treatment of mesangial cells with BaP
and ANTH completely inhibited EROD inducibility. In
the case of CHRY, co-treatment with BaP yielded an erratic
response, with less than additive interactions observed at
the lowest concentrations, and modest inhibition
observed as hydrocarbon concentrations increased.
AHH activity is also encoded by the Cyp1a1 and Cyp1b1
genes. BaP was a potent inducer of AHH activity in
mesangial cells, with concentration-dependent increases
observed over the full concentration range examined. A
greater than 40-fold induction in enzymatic activity was
observed at 30 µM BaP (Fig 4). Individual treatment with
ANTH or CHRY did not modulate AHH activity. Com-
bined treatment of mesangial cells with BaP and ANTH
repressed AHH activity at the lower BaP concentrations,
but the negative interaction was dissipated at higher con-
centrations. Likewise, CHRY inhibited AHH inducibility
by BaP, with greater than 50% reduction observed when
compared to cells treated with BaP alone.
Northern analysis of P-450 induction in rGMCs treated with BaP, ANTH and their binary mixtures Figure 1
Northern analysis of P-450 induction in rGMCs treated with BaP, ANTH and their binary mixtures. mRNA 
expression of Cyp1a1 in rGMCs challenged with BaP, ANTH and their binary mixtures for 24 hr (A). mRNA expression of 
Cyp1b1 in rGMCs challenged with BaP and ANTH and their binary mixtures for 24 hr (B). RNA extraction and analysis were 
performed as described in methodology. β-tubulin was analyzed to asses loading and transfer efficiency. These results shown 
are representative of three separate experiments.Journal of Carcinogenesis 2004, 3:12 http://www.carcinogenesis.com/content/3/1/12
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Cellular hydrocarbon uptake and metabolic profiles of 
PAHs
To further evaluate cellular mechanisms of toxicological
interactions in PAH mixtures, BaP metabolism was exam-
ined in mesangial cells treated with 30 µM BaP alone, or
in combination with 3 µM ANTH or 3 µM CHRY. At least
50% of the parent compound was reproducibly detected
in mesangial cells treated with BaP (Table 1). ANTH was
readily taken up by mesangial cells, and did not influence
the cellular uptake of BaP. 3-hydroxy-BaP was the primary
oxidative metabolite detected in mesangial cells treated
with BaP, with other metabolites representing less than
1% of the total metabolite pool detected (not shown).
Combined treatment of cells with ANTH significantly
reduced BaP metabolism, with greater than 80% reduc-
tion in detectable metabolite levels (Table 1A). Mesangial
cells readily took up CHRY, with greater than 77% of the
parent compound detected at the end of the treatment. As
with ANTH, CHRY did not influence the cellular uptake of
BaP. However, a 46% reduction in measurable 3-hydroxy-
BaP levels was observed in cells subjected to binary hydro-
carbon treatment (Table 1B).
Discussion
Cyp mRNA expression profiles and toxicological 
interactions
PAHs elicit a broad spectrum of toxic and carcinogenic
effects in multiple organ systems, including the kidney
[14]. To study the complexity of chemico-biological inter-
actions following exposures to multiple PAH carcinogens,
we evaluated the renal cell-specific response to binary and
ternary mixtures of BaP, ANTH and CHRY [3]. Challenge
of renal mesangial and cortico-tubular epithelial cells
with BaP in combination with ANTH or CHRY yielded
unexpected antagonistic interactions that may be partly
explained by differential regulation of enzymes involved
in PAH metabolism. Renal Cyp1a1 and Cyp1b1 are partic-
ularly relevant since these enzymes mediate the conver-
sion of PAHs to intermediates that induce oxidative stress
and bind covalently to DNA in the kidney, and are the
primary enzymes responsible for bioactivation of carcino-
genic PAHs in other tissues [6].
In mesangial cells,Cyp1a1 mRNA was undetectable under
constitutive conditions, highly inducible by BaP and
Northern analysis of P-450 induction in rGMCs treated with BaP, CHRY and their binary mixtures Figure 2
Northern analysis of P-450 induction in rGMCs treated with BaP, CHRY and their binary mixtures. mRNA 
expression of Cyp1a1 in rGMCs challenged with BaP and CHRY and their binary mixtures for 24 hr (A). mRNA expression of 
Cyp1b1 in rGMCs challenged with BaP and CHRY and their binary mixtures for 24 hr (B). RNA extraction and analysis were 
performed as described in methodology. β-tubulin was analyzed to asses loading and transfer efficiency. These results shown 
are representative of three separate experiments.Journal of Carcinogenesis 2004, 3:12 http://www.carcinogenesis.com/content/3/1/12
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CHRY, and refractory to ANTH (Figs 1 and 2). In contrast,
Cyp1b1  mRNA was constitutively expressed and highly
inducible by all three hydrocarbons. BaP and CHRY were
more potent inducers of Cyp1a1 and Cyp1b1 than ANTH
(Figs 1 and 2), a profile consistent with their relative
abilities to activate Ahr signaling in mammalian cells
(15). Shimada et al. [16] have shown that liver and lung
Cyp1a1 and Cyp1b1 mRNAs are highly induced in AhR(+/
+) mice by a single intraperitoneal injection of carcino-
genic PAHs, and that 6-aminochrysene, chrysene, benzo
[e]pyrene, and 1-nitropyrene weakly induced Cyp1a1 and
Cyp1b1  mRNAs, while non-carcinogenic hydrocarbons,
such as anthracene, pyrene, and fluoranthene, were poor
or inactive enzyme inducers. These findings indicate that
the toxicity and carcinogenicity profiles of PAHs may be
defined on the basis of their ability to regulate Cyp1a1 and
Cyp1b1 at either the mRNA or protein level.
The tissue-specific induction of Cyp1a1  and  Cyp1b1
mRNAs by PAHs and polychlorinated biphenyls (PCBs)
has been investigated in wildtype and AhR-deficient
C57BL/6J mice [17]. While expression of Cyp1a1 is AhR-
dependent, Cyp1b1 is constitutively expressed in various
organs in male and female Ahr (+/+) and Ahr (-/-) mice.
Cyp1b1  is of interest because it encodes for AHH and
EROD, the predominant PAH-metabolizing activities in
rodent embryos [17]. Important roles of Cyp1b1 in PAH
carcinogenesis have been proposed by Gonzalez and co-
workers [18-20] who observed that Cyp1b1  knock-out
mice expressing significant levels of Cyp1a1  are highly
resistant to lymphoma formation by 7,12-DMBA. In vitro
human studies with recombinant enzymes have shown
that Cyp1b1 is more active (about 10-fold) than Cyp1a1 in
the formation of BaP-7,8-diol [21].
CYP enzymatic activities and toxicological interactions
Measurements of EROD and AHH were used to monitor
kidney microsomal catalytic activities (Figs 3 and 4). The
profile of enzyme induction was significantly different
between BaP, ANTH and CHRY. The basal activities of
EROD and AHH were very low in control cultures, but
highly inducible in response to BaP and CHRY. BaP was
considerably more potent than ANTH as an inducer of
EROD and AHH, while CHRY only induced EROD activ-
ity. Interestingly, CHRY was a better inducer of Cyp1a1
mRNA, but induction at the mRNA level was not associ-
ated with corresponding increases of enzymatic activity.
The greater potency of BaP as an inducer of enzymatic
activities compared to ANTH and CHRY is consistent with
previous observations showing that BaP is the most toxic
PAH to renal mesangial cells [3]. The profiles of mRNA
and protein induction elicited by single exposures to BaP,
ANTH, and CHRY alone were markedly different from
those following challenge in binary mixture. ANTH
enhanced both Cyp1a1 and Cyp1b1 inducibility by BaP,
EROD activity in rGMCs treated with PAHs Figure 3
EROD activity in rGMCs treated with PAHs. EROD 
activity in rGMCs challenged with BaP, ANTH and CHRY 
alone or the binary mixtures of BaP with ANTH or CHRY. 
These results shown are representative of three separate 
experiments.
AHH activity in rGMCs treated with PAHs Figure 4
AHH activity in rGMCs treated with PAHs. AHH 
activity in rGMCs challenged with CHRY, ANTH and BaP 
alone or the binary mixtures of CHRY with ANTH or BaP. 
These results shown are representative of three separate 
experiments.Journal of Carcinogenesis 2004, 3:12 http://www.carcinogenesis.com/content/3/1/12
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but EROD and AHH activities were reduced in binary mix-
ture. CHRY, on the other hand, modestly inhibited
Cyp1a1 and Cyp1b1 mRNA inducibility by BaP and also
reduced AHH activity. Because both ANTH and CHRY
antagonize the mesangial cell response to BaP (3), these
findings implicate AHH as the primary enzymatic target
for antagonistic interactions among nephrotoxic PAHs.
Oxidative metabolic profiles and toxicological interactions
The above interpretation is supported by the marked inhi-
bition of 3-OH BaP formation seen in cells co-treated with
BaP and ANTH or CHRY (Table 1). A role for EROD in
mesangial cell injury cannot be ruled out, however, since
ANTH selectively antagonized EROD activity and inhib-
ited hydrocarbon metabolism. Thus, patterns of Cyp
inducibility and oxidative metabolism may account for
differences in the responses to BaP, ANTH and CHRY in
kidney cells, and their interactions in simple and complex
mixtures.
Conclusion
A major implication of our findings is that despite similar-
ities in gene and protein inducibility among structurally-
related PAHs, their behavior may be influenced by the
reactivity of oxidative intermediates generated during the
course of cellular metabolism. As such, PAH substrates in
complex mixtures may compete for, and inhibit, the same
metabolizing enzymes that act upon them to give rise to
antagonistic interactions that protect against further
chemical toxicity. Interactions of this nature are among
the most commonly encountered in environmental mix-
tures [22], but the magnitude and capacity of these
interactions for most relevant environmental nephrocar-
cinogens is unknown.
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